Why the study?
Does preoperative antiplatelet therapy increase bleeding and transfusion in ATAAD patients misdiagnosed as ACS undergoing emergency operation?
Population
Patients with Acute Type A Aortic Dissection (ATAAD) misdiagnosed as Acute Coronary Syndrome (ACS)
Design
Other
Authors
Loading...
Requires careful ACS-ATAAD differentiation before antiplatelet use; leaves open optimal timing and management strategies.
Does preoperative antiplatelet therapy increase bleeding and transfusion in ATAAD patients misdiagnosed as ACS undergoing emergency operation?
Preoperative antiplatelet therapy in ATAAD misdiagnosed as ACS increases bleeding and transfusion risks during emergency surgery, highlighting the need to carefully balance rupture and hemorrhage risks when timing operations.
Xue et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: